Tandem Diabetes Stock Plunge: National Security Probe Impact
Update: 2025-09-25
Description
Tandem Diabetes stock plummets after a U.S. national security probe into medical device imports threatens new tariffs and quotas, spooking investors. Is this a buying opportunity amidst the volatility, or a sign of deeper troubles for a company already down nearly 70% from its September 2024 peak?
Hosted on Acast. See acast.com/privacy for more information.
Comments
In Channel
Download from Google Play
Download from App Store
United States00:00
00:00
1.0x
